Delivery Order SPE2DB20D3101-SPE2DB21FK4Z0

Award Date 9/10/21
Potential Completion Date 9/13/21
Potential Value $3.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Novolin 70-30 Flexpen 3ML, a prescription insulin medication. The contract has a ceiling value of $2,244.40 and a completion date of April 12, 2023. The contract is a firm fixed-price delivery order without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,999.40, is for the delivery of Novolin N 100 Unit/mL Flexpen 3mL, a type of insulin product. The contract has an ultimate completion date of January 31, 2024, and is a Firm Fixed Price Delivery Order. The contract was awarded on January 30, 2024, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $5,088.58 firm fixed-price delivery order is for the supply of NovologTM 100 unit/mL FlexPen 3mL insulin pens. This order is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Amerisourcebergen, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,212.36 firm fixed-price delivery order is for the supply of Novolin R 100 unit/mL Flexpen 3mL, a type of insulin medication. The contract has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,473.04 firm fixed price delivery order is for the supply of Novolin N 100 Unit/mL Flexpen 3mL, a prescription insulin product. The contract has an ultimate completion date of May 17, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,403.08 firm fixed-price delivery order is for the supply of NovologTM 100 unit/mL FlexPen 3mL, a prescription insulin product. The contract has an ultimate completion date of November 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of NovologⓇ 100 Unit/mL FlexPenⓇ 3mL insulin pens. The $1,089.28 firm fixed-price delivery order was placed by the Defense Logistics Agency, a defense agency, and has a completion date of June 5, 2024. The award is not associated with a set-aside program. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 single-award Indefinite Delivery Contract with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,200.97, is a delivery order for NOVOLOG MIX 70-30 FLEXPEN 3ML, a type of insulin medication. The contract has an ultimate completion date of March 18, 2025 and is a firm fixed-price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Novolog 100 Unit/mL FlexPen 3mL insulin products. The $1,810.80 fixed-price delivery order has a completion date of September 27, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as the primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Novolog 100 Unit/mL Flexpen 3mL insulin pens. The contract has a ceiling value of $3,111.20 and a period of performance through May 31, 2024. It is a firm fixed price delivery order contract, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB21FK4Z0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $3,868.51 Firm Fixed Price Delivery Order covers the supply of Novolin 70-30 Flexpen 3ML, a type of insulin medication used to treat diabetes. The contract has an ultimate completion date of September 13, 2021 and was awarded on September 10, 2021.

Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. Both companies are for-profit organizations registered in the System for Award Management (SAM.gov). The contract does not have a set-aside designation, indicating full and open competition.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.

Generated 2/27/25, 11:50 AM